MIT Libraries logoDSpace@MIT

MIT
View Item 
  • DSpace@MIT Home
  • MIT Open Access Articles
  • MIT Open Access Articles
  • View Item
  • DSpace@MIT Home
  • MIT Open Access Articles
  • MIT Open Access Articles
  • View Item
JavaScript is disabled for your browser. Some features of this site may not work without it.

SHMT2 drives glioma cell survival in ischaemia but imposes a dependence on glycine clearance

Author(s)
Kami, Kenjiro; Shelton, Laura M.; Ramkissoon, Shakti H.; Ligon, Keith L.; Snuderl, Matija; Kim, Dohoon; Fiske, Brian Prescott; Birsoy, Kivanc; Freinkman, Elizaveta; Possemato, Richard; Chudnovsky, Yakov; Chen, Walter W.; Cantor, Jason R.; Gui, Dan Yi; Kwon, ManJae; Kang, Seong Woo; Vander Heiden, Matthew G.; Sabatini, David; Pacold, Michael Edward; ... Show more Show less
Thumbnail
DownloadSHMT2 drives.pdf (4.036Mb)
PUBLISHER_POLICY

Publisher Policy

Article is made available in accordance with the publisher's policy and may be subject to US copyright law. Please refer to the publisher's site for terms of use.

Terms of use
Article is made available in accordance with the publisher's policy and may be subject to US copyright law. Please refer to the publisher's site for terms of use.
Metadata
Show full item record
Abstract
Cancer cells adapt their metabolic processes to support rapid proliferation, but less is known about how cancer cells alter metabolism to promote cell survival in a poorly vascularized tumour microenvironment1, 2, 3. Here we identify a key role for serine and glycine metabolism in the survival of brain cancer cells within the ischaemic zones of gliomas. In human glioblastoma multiforme, mitochondrial serine hydroxymethyltransferase (SHMT2) and glycine decarboxylase (GLDC) are highly expressed in the pseudopalisading cells that surround necrotic foci. We find that SHMT2 activity limits that of pyruvate kinase (PKM2) and reduces oxygen consumption, eliciting a metabolic state that confers a profound survival advantage to cells in poorly vascularized tumour regions. GLDC inhibition impairs cells with high SHMT2 levels as the excess glycine not metabolized by GLDC can be converted to the toxic molecules aminoacetone and methylglyoxal. Thus, SHMT2 is required for cancer cells to adapt to the tumour environment, but also renders these cells sensitive to glycine cleavage system inhibition.
Date issued
2015-04
URI
http://hdl.handle.net/1721.1/106619
Department
Harvard University--MIT Division of Health Sciences and Technology; Massachusetts Institute of Technology. Department of Biology; Whitehead Institute for Biomedical Research; Koch Institute for Integrative Cancer Research at MIT
Journal
Nature
Publisher
Nature Publishing Group
Citation
Kim, Dohoon et al. “SHMT2 Drives Glioma Cell Survival in Ischaemia but Imposes a Dependence on Glycine Clearance.” Nature 520.7547 (2015): 363–367.
Version: Author's final manuscript
ISSN
0028-0836
1476-4687

Collections
  • MIT Open Access Articles

Browse

All of DSpaceCommunities & CollectionsBy Issue DateAuthorsTitlesSubjectsThis CollectionBy Issue DateAuthorsTitlesSubjects

My Account

Login

Statistics

OA StatisticsStatistics by CountryStatistics by Department
MIT Libraries
PrivacyPermissionsAccessibilityContact us
MIT
Content created by the MIT Libraries, CC BY-NC unless otherwise noted. Notify us about copyright concerns.